ELIAS SOTIRCHOS

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology BALTIMORE, MD NPI 1821331364

General Payments — all program years on this page

$64,335.02

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 72
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $13,833.68 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $7,344.2111
Alexion Pharmaceuticals, Inc. $6,390.002
GENZYME CORPORATION $99.471

By program year

Program yearAmountRecords
2019 $4,773.205
2020 $3,315.001
2021 $22,413.2016
2022 $16,360.2732
2023 $3,639.674
2024 $13,833.6814

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093953424 Alexion Pharmaceuticals, Inc. $3,550.00 12/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1094049375 Alexion Pharmaceuticals, Inc. $2,840.00 09/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1111713836 Amgen Inc. $71.98 01/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111713838 Amgen Inc. $6,050.00 01/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1111713840 Amgen Inc. $124.97 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111713842 Amgen Inc. $14.56 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111713844 Amgen Inc. $14.56 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111713846 Amgen Inc. $283.81 01/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111713848 Amgen Inc. $315.21 01/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111713850 Amgen Inc. $350.00 01/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111713852 Amgen Inc. $50.00 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111713854 Amgen Inc. $65.00 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111713856 Amgen Inc. $4.12 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139928591 GENZYME CORPORATION $99.47 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.